When Should Intermediates Start Using Support Compounds?

Bioavailability limits compound reaching effective concentrations in tissues.

Lab environments remove stress variables affecting real responses.

Exogenous GH offers precise control over dosing amounts.

Natural pulsatility reduces shutdown risk compared injections alone.

Whole body feedback loops alter biological effects significantly.

Safety profiles differ between cells and organisms greatly.

Both approaches useful depending goals physiology individual response.